Therapeutic Solutions International Inc (TSOI) 0.0061

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Therapeutic Solutions International Inc (TSOI) 0.0061 $TSOI

Therapeutic Solutions International Announces New Liposomal Products
Marketwire Canada - Wed Jun 22, 8:02AM CDT
OCEANSIDE, CA--(Marketwired - June 22, 2016) - Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the addition of four new consumer products to our nutraceutical division.

Therapeutic Solutions International's Subsidiary MolecuVax, Inc. Announces Licensing of "Universal Cancer Vaccine" With Demonstrated Efficacy in Breast Cancer
Marketwired - Mon May 09, 8:02AM CDT
Clinical Stage Immunotherapy Company Expands Its Intellectual Property Portfolio by Exclusive Licensing of Issued Patents

Therapeutic Solutions International Files Patent Covering ProJuvenol(C) and Its Active Ingredient Pterostilbene
Marketwired - Thu Apr 28, 8:02AM CDT
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering the use of ProJuvenol© and its active ingredient pterostilbene for augmentation of stem cell activity. Diseases such as diabetes(1), cardiovascular disease(2), and neurodegenerative diseases(3) are characterized by deficient stem cell activity. The patent covers the stimulation of stem cells that already exist in the patient's body, as well as stem cells that are administered therapeutically.

Therapeutic Solutions International's Subsidiary MolecuVax, Inc. to Initiate Cancer Immunotherapy Clinical Trial Aimed at Eradicating Cancer Stem Cells Using MVAX-001
Marketwired - Mon Apr 11, 8:02AM CDT
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an agreement between its subsidiary, MolecuVax, Inc., (MVAX) and the Pan Am Cancer Treatment Center covering production and clinical implementation of a novel cancer immunotherapy based around MVAX's proprietary Brother of the Regulator of Imprinted Sites (BORIS) peptide/exosome technology.

Therapeutic Solutions International Licenses Dexosome Clinical Stage Cancer Immunotherapy Product From Gustave Roussy European Cancer Centre
Marketwired - Mon Jan 25, 8:02AM CST
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the signing of an exclusive intellectual property license agreement with Gustave Roussy Transfert of Villejuif, France for an issued U.S. patent covering the clinically tested "Dexosome" cancer immunotherapy product.

Therapeutic Solutions International Announces the Appointment of BioPharmaceutical Pioneer Thomas E. Ichim, Ph.D to Board of Directors
Marketwired - Fri Jan 22, 8:00AM CST
Therapeutic Solutions International, Inc., (OTC PINK: TSOI) announced today the appointment of Dr. Thomas E. Ichim to our Board of Directors.

Therapeutic Solutions International Announces the Licensing of Probiotic Technology to OmniBiome, Inc.
Marketwired - Tue Dec 08, 7:55AM CST
Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed an additional Patent to OmniBiome, Inc. (Omni), a wholly owned subsidiary of Therapeutic Solutions International, Inc., focused on Fetal-Maternal Health.

Therapeutic Solutions International Files Patent on Anticancer Nanotechnology Based Immunotherapy
Marketwired - Mon Nov 23, 7:55AM CST
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today a patent for developing a future generation of immune cell derived nanoparticles, termed exosomes, as a means of selectively stimulating the body's own natural defense mechanisms to seek and destroy cancer cells by company collaborators.

Therapeutic Solutions International Announces the Licensing of Patents to OmniBiome and the Appointment of Iryna Dzieciuch, M.S. as Chief Executive Officer of OmniBiome
Marketwired - Wed Nov 18, 7:55AM CST
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that the Company has licensed three Patents to OmniBiome, Inc. ("OmniBiome" a wholly owned subsidiary of Therapeutic Solutions International, Inc. ("TSI" focused on Fetal-Maternal Health, with the Company's goal to assist women in the treatment or prevention of pre-term birth and pregnancy complications.

Therapeutic Solutions International Announces the Appointment of Michael G. Agadjanyan, Ph.D. to Company Scientific Advisory Board
Marketwired - Mon Oct 19, 7:55AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Michael Agadjanyan, Ph.D. has been appointed to our Scientific Advisory Board.

Therapeutic Solutions International Announces the Appointment of Harry M. Lander, Ph.D. to the TSI Scientific Advisory Board
Marketwired - Mon Oct 12, 7:55AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today that Harry M. Lander, Ph.D. has been appointed to our Scientific Advisory Board.

Therapeutic Solutions International, Inc. Announces the Appointment of Santosh Kesari, M.D., Ph.D. to Company Scientific Advisory Board
Marketwired - Tue Oct 06, 7:50AM CDT
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today that Santosh Kesari, M.D., Ph.D., FANA, FAAN, has been appointed to our Scientific Advisory Board.

Therapeutic Solutions International Files Patent on Immune Therapy Medical Device to Prevent Preterm Labor
Marketwired - Tue Sep 29, 7:50AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announces the filing of U.S. Patent No. 62/232722 titled "A Medical Device For Reducing The Risk Of Preterm-Labor And Preterm-Birth," covering various medical devices aimed at immune modulating the cervical microenvironment in order to prevent preterm labor.

Therapeutic Solutions International Develops Cytokine Based Diagnostic Test for Preterm Labor and Complications of Pregnancy
Marketwired - Mon Sep 21, 8:00AM CDT
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today the development of a cytokine-based diagnostic kit aimed at stratifying risk of preterm labor and other pregnancy associated complications.

Therapeutic Solutions International Announces Engagement With PLS CPA's
Marketwired - Tue Sep 15, 7:45AM CDT
Therapeutics Solutions International, Inc. (OTC PINK: TSOI) announced today the signing of an engagement with PLS CPA, A PC of San Diego CA. On September 10, 2015, Therapeutic Solutions International, Inc. (the "Company", approved the engagement of PLS CPA's ("PLS" as the Company's independent registered public accounting firm beginning with the fiscal year ended December 31, 2013. The engagement of PLS has been approved by the Board of Directors of the Company on September, 10 2015.

Therapeutic Solutions International Files Patient on Cytokine Modulation to Prevent Pregnancy Loss and Pre-Term Labor
Marketwired - Tue Sep 08, 7:45AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering novel means of modulating the immune system to prevent miscarriages and preterm labor. The filed patent covers utility of vaccines and various agents to alter pathological conditions in which the maternal immune system induces a process of inflammation that culminates in placental alterations leading to either fetal loss or preterm labor. To the knowledge of the company, this is one of the only experimental approaches in development for addressing this unmet medical need.

Therapeutic Solutions International Files Patent on Cancer Immune Modulation Using Its ProJuvenol(TM) Product
Marketwired - Thu Jul 09, 7:30AM CDT
Therapeutics Solutions International, Inc., (OTC PINK: TSOI) announced today the filing of a patent application covering the use of its ProJuvenol(TM) product, as well as various pterostilbene compositions, for use in augmenting efficacy of existing immuno-oncology drugs that are currently on the market. The patent is based on the ability of pterostilbene, one of the major ingredients of ProJuvenol(TM), to reduce oxidative stress produced by cancer cells, which in turn protects the immune system from cancer mediated immune suppression.

Therapeutic Solutions Announces Shipping of ProJuvenol(TM) and T-Rx(TM)
Marketwired - Mon May 18, 7:45AM CDT
Therapeutic Solutions International, Inc. (OTC PINK: TSOI) announced today the availability of our flagship product ProJuvenol(TM).

Scroll down for more posts ▼

Top 10 Most Recent News Articles

LONGi's Four Paths to Global Green Development

Updated Category News Views 41

LONGi's Vision: A Cleaner, Greener Future Amidst the buzz at COP31 in Antalya, LONGi is making waves with promises of a cleaner future. They're not just throwing around eco-friendly slogans—this company's laying down real pathways to tackle climate change, one solar panel at a time. Aiming for Industrial Transformation LONGi's got their sights set on shaking up...

Continue Reading
KINGRVER Boosts RV Comfort with New Water Heater Lineup

Updated Category News Views 328

An Upgrade for the Open Road In the land of RV living, comfort is king—or in this case, KINGRVER. Dropping affordable upgrades for water heaters into the world of RVs, KINGRVER's CT6 lineup is like a warm hug on a chilly campsite morning. Whether you've pulled up to a wooded retreat or parked under the vast desert sky, having dependable hot water shouldn't be a gamble....

Continue Reading
Hanwha Power Seals Second FSRU Conversion Deal

Updated Category News Views 71

Riding the FSRU Wave with Hanwha Power Alright, we've got Hanwha Power step-dancing onto the LNG stage with its second splash into the FSRU (Floating Storage and Regasification Unit) conversion gig. Partnering up with Energos Infrastructure, these guys are making serious waves in the energy market by transforming what's pretty much a regular ship into a floating gas...

Continue Reading
Employment Law Suit Hits ABC: Alleged Wage Violations

Updated Category News Views 199

ABC Under Fire for Labor Code Violations You know it's a rocky road when a company like American Broadcasting Companies, Inc. lands itself in hot water with accusations riding high on labor law violations. People yapping about lunch breaks? Well, that’s the ball game here. Meal and Rest Break Controversies According to a recent lawsuit filed by Blumenthal Nordrehaug...

Continue Reading
Local Voices to Shape Mekong's Story in New Alliance

Updated Category News Views 167

Unpacking the New Storytelling Strategy Right off the bat, let's make it clear—this isn't just another run-of-the-mill environmental project announcement. When the National Geographic Society teams up with ThaiBev to empower Southeast Asian storytellers, they're not just waving around the usual conservation banner. Instead, they're betting on local voices to lead the...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 258

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading
CVS Study: GLP-1 Drugs Effective But Costly

Updated Category News Views 157

Can GLP-1s Deliver Value at Their Current Price? Alright, folks, here's a real-world gut check from CVS Health. They crunched some numbers using Aetna's anonymized claims data, and the results are eye-opening. These GLP-1s are showing promising health outcomes—lower hospital visits, better clinical results, yada yada. But when it comes to savings, they ain't quite...

Continue Reading
FFR's Michigan Milestone and Major Robotics Update

Updated Category News Views 152

Nobody's going to argue that breaking into new territories isn't a gamble, but sometimes you just need to roll the dice. FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is banking on their move with Aegis Ultra robots, making an academic splash at Central Michigan University. This isn't just about ticking off another state; it's about stacking the deck with new...

Continue Reading
Pan-Mass Challenge Gifts $80M to Dana-Farber for 2026

Updated Category News Views 249

A Momentous Gift in a Crunch Time for Cancer Research Biking and philanthropy might seem like an odd duo, but let me tell you, the Pan-Mass Challenge (PMC) is making that partnership look like peanut butter and jelly. This year, PMC rolled out a jaw-dropping $80 million gift to the Dana-Farber Cancer Institute. You heard right—eighty million smackeroos. Talk about going...

Continue Reading

Top 5 Most Recently Viewed Articles

Roche Unveils High-Sensitivity Troponin T Test Increasing Diagnosis Precision

Updated Category News Views 350

The Unveiling of Roche's Sixth-Generation Troponin T Test Roche has recently been granted a CE Mark for its innovative sixth-generation Troponin T test, which promises to deliver a new level of accuracy that is critical for diagnosing heart attacks. This novel testing solution is designed to enhance sensitivity and precision, allowing for quicker and more reliable...

Continue Reading
Maximize Your Earnings with Keurig Dr Pepper Stock Strategy

Updated Category News Views 133

Understanding Keurig Dr Pepper's Earnings Potential Keurig Dr Pepper Inc. (NASDAQ: KDP) is preparing to share its third quarter earnings results shortly. Investors eagerly await the disclosures, which are expected to highlight positive financial trends and growth. Analysts predict that the company will report earnings per share of 54 cents, an increase from 51 cents in...

Continue Reading
Uwharrie Capital Corp Celebrates Year-End Financial Growth

Updated Category News Views 113

Uwharrie Capital Corp Reports Strong Year-End Results Uwharrie Capital Corp and its subsidiary, Uwharrie Bank, have recently unveiled impressive financial results that reflect their continued strength and stability in the banking sector. The company reported consolidated total assets of $1.13 billion at the end of the reporting period, demonstrating a noticeable increase...

Continue Reading
Enhancing California's Tourism Appeal with Interactive Design

Updated Category News Views 148

Revolutionizing Tourism Through Interactive Web Design In today's fast-paced digital world, engaging younger travellers has become crucial for tourism boards in California. Digital Silk, an award-winning agency renowned for its expertise in digital marketing and web design, is leading the charge to inspire Generation Z and millennials by advocating for the adoption of...

Continue Reading
FOX News Digital Dominates October with Record-Breaking View Counts

Updated Category News Views 174

FOX News Digital Achieves Historic Success in October Leading YouTube with 377 Million Video Views During the month of October, FOX News Digital achieved outstanding milestones, topping the charts in multiplatform engagement. With a staggering 3.7 billion multiplatform minutes and 1.8 billion views, the platform outshined its competitors, establishing its dominance in the...

Continue Reading